Results 1 to 10 of about 97,402 (243)

C2PO: an ML-powered optimizer of the membrane permeability of cyclic peptides through chemical modification [PDF]

open access: yesJournal of Cheminformatics
Peptide drug development is currently receiving due attention as a modality between small and large molecules. Therapeutic peptides represent an opportunity to achieve high potency, selectivity, and reach intracellular targets.
Roy Aerts   +6 more
doaj   +2 more sources

Identification of a novel and high-affinity cyclic peptide targeting Keap1 for inflammation treatment by a combined virtual screening strategy [PDF]

open access: yesJournal of Enzyme Inhibition and Medicinal Chemistry
Inhibition of the Keap1-Nrf2 protein-protein interaction with cyclic peptides represents an attractive strategy to treat inflammation. However, the cyclic peptides for this inhibition are constrained by their low affinity. In this study, the peptides 1-6
Shenglin Gao   +5 more
doaj   +2 more sources

HighFold-MeD: a Rosetta distillation model to accelerate structure prediction of cyclic peptides with backbone N-methylation and d-amino acids [PDF]

open access: yesJournal of Cheminformatics
Abstract Cyclic peptides with backbone N-methylated amino acids (BNMeAAs) and D-amino acids (D-AAs) have gained increasing attention for their stability, membrane permeability, and other therapeutic potentials.
Zhigang Cao   +6 more
doaj   +2 more sources

Plant derived cyclic peptides [PDF]

open access: yesBiochemical Society Transactions, 2021
Cyclic peptides are widespread throughout the plant kingdom, and display diverse sequences, structures and bioactivities. The potential applications attributed to these peptides and their unusual biosynthesis has captivated the attention of researchers for many years.
Norelle L. Daly, David T. Wilson
openaire   +3 more sources

Cyclic Peptides with Antifungal Properties Derived from Bacteria, Fungi, Plants, and Synthetic Sources

open access: yesPharmaceuticals, 2023
Fungal infections remain a significant concern for human health. The emergence of microbial resistance, the improper use of antimicrobial drugs, and the need for fewer toxic antifungal treatments in immunocompromised patients have sparked substantial ...
Naiera M. Helmy, Keykavous Parang
doaj   +1 more source

Cyclic Peptides in Pipeline: What Future for These Great Molecules?

open access: yesPharmaceuticals, 2023
Cyclic peptides are molecules that are already used as drugs in therapies approved for various pharmacological activities, for example, as antibiotics, antifungals, anticancer, and immunosuppressants.
Lia Costa   +2 more
doaj   +1 more source

Cyclic Opioid Peptides [PDF]

open access: yesCurrent Medicinal Chemistry, 2016
For decades the opioid receptors have been an attractive therapeutic target for the treatment of pain. Since the first discovery of enkephalin, approximately a dozen endogenous opioid peptides have been known to produce opioid activity and analgesia, but their therapeutics have been limited mainly due to low blood brain barrier penetration and poor ...
Michael, Remesic   +2 more
openaire   +2 more sources

Comparison of Collisional Fragmentation Pathways of Sodiated and Protonated Cyclic Peptide Analogs [PDF]

open access: yesZhipu Xuebao, 2023
Cyclic peptides and their related species have been shown a unique class of molecules characterized by their biological function and structural diversity.
DU Meng-ying1;JIAO Lu-yang1;XU Yi-cheng1;LI Shu-qi1;CUI Yong-liang1;ZHANG Sen1;KONG Xiang-lei1,2,3
doaj   +1 more source

More than skin deep: cyclic peptides as wound healing and cytoprotective compounds

open access: yesFrontiers in Cell and Developmental Biology, 2023
The prevalence and cost of wounds pose a challenge to patients as well as the healthcare system. Wounds can involve multiple tissue types and, in some cases, become chronic and difficult to treat.
Ying-Chiang J. Lee   +3 more
doaj   +1 more source

Anchor extension: a structure-guided approach to design cyclic peptides targeting enzyme active sites

open access: yesNature Communications, 2021
Cyclic peptides are of particular interest due to their pharmacological properties, but their design for binding to a target protein is challenging. Here, the authors present a computational “anchor extension” methodology for de novo design of cyclic ...
Parisa Hosseinzadeh   +17 more
doaj   +1 more source

Home - About - Disclaimer - Privacy